Mike Polark
Stock Analyst at Baird
(3.40)
# 978
Out of 4,761 analysts
77
Total ratings
48.89%
Success rate
5.49%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Maintains: Outperform | $252 → $248 | $177.32 | +39.86% | 6 | Feb 11, 2025 | |
| EW Edwards Lifesciences | Downgrades: Underperform | $60 | $73.30 | -18.14% | 4 | Jan 16, 2025 | |
| NVRO Nevro | Maintains: Neutral | $5 → $6 | $5.73 | +4.71% | 10 | Nov 12, 2024 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $100 → $79 | $119.44 | -33.86% | 7 | Nov 1, 2024 | |
| RMD ResMed | Downgrades: Underperform | $180 | $231.69 | -22.31% | 5 | Sep 18, 2024 | |
| ZBH Zimmer Biomet Holdings | Initiates: Peer Perform | n/a | $104.83 | - | 1 | Sep 10, 2024 | |
| SYK Stryker | Initiates: Outperform | $405 | $382.78 | +5.80% | 1 | Sep 10, 2024 | |
| LIVN LivaNova | Maintains: Neutral | $55 | $47.44 | +15.94% | 8 | Aug 28, 2024 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $487 → $503 | $591.79 | -15.00% | 7 | Jul 19, 2024 | |
| PODD Insulet | Upgrades: Outperform | $200 | $282.80 | -29.28% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $134.92 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $175.64 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $88.78 | +36.29% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $31.00 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $13.52 | +84.91% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $169.96 | -2.92% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $104.49 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | n/a | $89.94 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $13.77 | -5.59% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $10.35 | +102.96% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $220.56 | +13.35% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $2.08 | +1,967.31% | 1 | Sep 2, 2020 |
Inspire Medical Systems
Feb 11, 2025
Maintains: Outperform
Price Target: $252 → $248
Current: $177.32
Upside: +39.86%
Edwards Lifesciences
Jan 16, 2025
Downgrades: Underperform
Price Target: $60
Current: $73.30
Upside: -18.14%
Nevro
Nov 12, 2024
Maintains: Neutral
Price Target: $5 → $6
Current: $5.73
Upside: +4.71%
iRhythm Technologies
Nov 1, 2024
Maintains: Outperform
Price Target: $100 → $79
Current: $119.44
Upside: -33.86%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $231.69
Upside: -22.31%
Zimmer Biomet Holdings
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $104.83
Upside: -
Stryker
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $382.78
Upside: +5.80%
LivaNova
Aug 28, 2024
Maintains: Neutral
Price Target: $55
Current: $47.44
Upside: +15.94%
Intuitive Surgical
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $591.79
Upside: -15.00%
Insulet
May 7, 2024
Upgrades: Outperform
Price Target: $200
Current: $282.80
Upside: -29.28%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $134.92
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $175.64
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $88.78
Upside: +36.29%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $31.00
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $13.52
Upside: +84.91%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $169.96
Upside: -2.92%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $104.49
Upside: -
Jul 6, 2022
Initiates: Underperform
Price Target: n/a
Current: $89.94
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $13.77
Upside: -5.59%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $10.35
Upside: +102.96%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $220.56
Upside: +13.35%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $2.08
Upside: +1,967.31%